Novel Peptidomimetic Cyclo-{E(I)-E(W)}Na (CP-88) with Hematopoietic Activity Sustained in Invasive and Oral Administration: Experimental and Preclinical Evaluation
Animal research · 2024
- What was studied
- Source-specific experimental population
- Main finding
- Mouse and laboratory experiments report colony-forming activity, CD34-positive-cell changes and NF-κB reporter activation. These do not establish long-term stem-cell self-renewal, direct Toll-like-receptor binding or a causal NF-κB mechanism. Oral experimental activity does not establish human pharmacokinetics; preclinical safety extrapolations are not safe human doses.
Intact-mouse spleen colony formation · Control 14.5±1.6 colonies per 100,000 cells; CP-88 injected 19.9±1.3, oral 19.3±1.3; both marked p<0.05 versus control.
Reported findings and study design
Population or model Source-specific experimental population
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Intact-mouse spleen colony formation | Control 14.5±1.6 colonies per 100,000 cells; CP-88 injected 19.9±1.3, oral 19.3±1.3; both marked p<0.05 versus control. | |
| Stemokin in the same table | 14.7±0.7 injected and 14.3±1.8 oral; neither carries a significance mark. |
No CP-88-versus-Stemokin significance is established by separate control tests. Table 2 footnotes and Table 3 marker/header labels need clarification. Colony formation does not establish long-term stem-cell self-renewal or human benefit.
Source for these results ↗ · Reviewed 2026-11-06
Study limitations and source details
Study limitations
- Independent replication and full risk-of-bias appraisal remain unresolved.
- No personalized treatment or safety conclusion follows from this record.
Source details
Original full text retrieved from Europe PMC; experimental scope and interpretation checked. Supplementary methods and independent replication remain review targets.
Original XML; Table 1 extracted, Tables 2–3 reporting ambiguities flagged
Sources checked
Citation
Vladislav Deigin, Yulia Vinogradova, Dmitriy Vinogradov, Natalia Linkova, Anastasiia Dyatlova, Dmitrii Medvedev, Alexander Krasichkov, Victoria Polyakova. Novel Peptidomimetic Cyclo-{E(I)-E(W)}Na (CP-88) with Hematopoietic Activity Sustained in Invasive and Oral Administration: Experimental and Preclinical Evaluation International Journal of Molecular Sciences 25(24):13385
Study source ↗ · DOI 10.3390/ijms252413385 · Bibliography entry · Link to this summary
Related compounds
CP-88
An experimental cyclic peptidomimetic. Mouse and laboratory studies examined its effects on hematopoiesis, the formation of blood cells.
Stemokin / Neogen
A synthetic three-amino-acid peptide (Ile–Glu–Trp), also called Neogen, studied in blood-cell and immune research.